EQL Pharma to discuss second quarter 2026/27 financial results on November 5

EQL Pharma is scheduled to publish its interim financial report for the second quarter of the 2026/27 fiscal year on Thursday, November 5, 2026.

Following the publication, CEO and President Axel Schörling will conduct a live video conference at 10:00 CET to review the quarterly performance and address inquiries from shareholders and market participants.

The event serves as a platform for investors to examine the company's financial health and strategic updates for the current period. Interested parties can access the session via the company's provided video conferencing link.